This company seems to have been delisted
Reason: Failure to Satisfy a Continued Listing Rule or Standard
Last recorded trade on: April 18, 2025
Source: https://www.sec.gov/Archives/edgar/data/1166272/000149315224049733/ex99-1.htm
Reason: Failure to Satisfy a Continued Listing Rule or Standard
Last recorded trade on: April 18, 2025
Source: https://www.sec.gov/Archives/edgar/data/1166272/000149315224049733/ex99-1.htm
Genetic Technologies
GENE
£0.57
Share price
0.00%
Change (1 day)
-69.82%
Change (1 year)
Categories
Revenue for Genetic Technologies (GENE)
Revenue in 2008 (TTM): £8.51 Million
According to Genetic Technologies's latest financial reports the company's current revenue (TTM 
) is £12.67 Million. In 2007 the company made a revenue of £8.37 Million an increase over the revenue in the year 2006 that were of £3.57 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Genetic Technologies from 2005 to 2008
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2008 (TTM) | £8.51 M | 1.73% |
| 2007 | £8.37 M | 133.95% |
| 2006 | £3.57 M | -11.58% |
| 2005 | £4.04 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Eterna Therapeutics ERNA | £0.39 M | -96.87% | 🇺🇸 USA |
 Myriad Genetics MYGN | £0.61 B | 4,760.59% | 🇺🇸 USA |
 LabCorp LH | £9.76 B | 76,947.97% | 🇺🇸 USA |
 Quest Diagnostics
DGX | £7.52 B | 59,293.61% | 🇺🇸 USA |
 Compugen CGEN | £20.45 M | 61.31% | 🇮🇱 Israel |
 Danaher DHR | £17.65 B | 139,175.02% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | £31.79 B | 250,723.68% | 🇺🇸 USA |
 Neogen NEOG | £0.67 B | 5,197.34% | 🇺🇸 USA |